News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
From Risk to Hyper-Precision: How ViTAA Medical is leveraging imaging and AI to redefine Aortic Aneurysm Care
Using AI-assisted 3D modelling, ViTAA Medical is determined to bring aneurysm management into the 21st century. For the last 15 years, Dr. Elena Di Martino, a biomedical engineer and Dr. Randy Moore, a vascular surgeon (both teach at the University of Calgary), have been perfecting technology that uses computer algorithms to analyze information gathered on a CT scan to create 3D models of aneurysms that encode the actual mechanical properties of the vessel’s wall.
INOVAIT and the Government of Canada announce latest Pilot Fund recipients at ALL IN 2025
INOVAIT, Canada’s membership network promoting image-guided therapy (IGT) and artificial intelligence (AI) technology innovations, announced that they will present their latest Pilot Fund recipients at SCALE AI’s 2025 ALL IN event at the Palais des congrès in Montreal, Quebec.
INOVAIT to announce latest Pilot Fund recipients at ALL IN 2025
INOVAIT, Canada’s membership network promoting image-guided therapy (IGT) and artificial intelligence (AI) technology innovations, announced that they will present their latest Pilot Fund recipients at SCALE AI’s 2025 ALL IN event at the Palais des congrès in Montreal, Quebec.
Network News
INOVAIT launches Canada-wide medtech job board to connect talent with innovation
Developed in response to increasing demand from our members and job seekers, the INOVAIT Network Job Board offers job seekers direct access to high-impact roles at some of the country’s top companies working in emerging medical technologies. Updated daily, the platform features listings from across the INOVAIT network and is designed to help talented professionals launch or advance their careers in a home-grown company right here in Canada.
Cohesic flips the script on incorporating AI into healthcare
Jordan Engbers, Chief Science Officer of Cohesic, a data scientist who spent years in clinical research, is painfully aware of the chasm between the promise and reality of AI in healthcare. While an AI model might work within a study where researchers systematically gather, clean up, and standardize the data, real-world healthcare data is often too messy and unreliable to use for clinical decisions.
Seeing beneath the surface: How MIMOSA is transforming wound care
Dr. Karen Cross, a plastic and reconstructive surgeon and CEO of MIMOSA Diagnostics, saw countless patients with diabetes and chronic wounds in her clinic. People with diabetes have an increased risk of developing pressure wounds due to complications like poor circulation and nerve damage. Many of her patients came into her clinic too late to prevent complications and ultimately had lower extremity amputations to prevent fatal infections.
INOVAIT publishes framework for responsibly unlocking Canadian health data for innovation and better patient care
Industry members in the INOVAIT Network are developing AI technologies that are revolutionizing the diagnosis and treatment of disease and improving patient outcomes while building the Canadian healthcare economy. The health data these companies need to create their technologies most often reside with Canadian healthcare institutions that are reluctant to share data with commercial partners due to caution stemming from a lack of clarity in privacy legislation and historical practices focused primarily on minimizing privacy and security risks.
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media
The Network in the Press
